Мақаланы E-mail арқылы жіберу Synthesis of 177Lu-based bioconjugate for radioimmunotherapy and evaluation of its stability in physiological media
- Авторлар: Nurtdinov E.F.1, Proshin M.A.1, Chuvilin D.Y.1
-
Мекемелер:
- National Research Centre Kurchatov Institute
- Шығарылым: Том 58, № 2 (2016)
- Беттер: 171-176
- Бөлім: Article
- URL: https://journals.rcsi.science/1066-3622/article/view/223360
- DOI: https://doi.org/10.1134/S1066362216020107
- ID: 223360
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
Labeling of the conjugated molecule of human serum albumin (HSA) and humanized scFv 4D5 mini-antibody specific to her-2/neu receptor with β-emitting 177Lu radionuclide via p-SCN-benzyl-DTPA chelator was studied. The radioconjugate can be prepared with the decay-corrected radiochemical yield of 82%. The stability of the synthesized complex in physiological solutions (normal saline, human blood serum) was evaluated. The complex is stable in physiological solutions for no less than 10 days.
Авторлар туралы
E. Nurtdinov
National Research Centre Kurchatov Institute
Хат алмасуға жауапты Автор.
Email: nurtdinov@list.ru
Ресей, pl. Akad. Kurchatova 1, Moscow, 123182
M. Proshin
National Research Centre Kurchatov Institute
Email: nurtdinov@list.ru
Ресей, pl. Akad. Kurchatova 1, Moscow, 123182
D. Chuvilin
National Research Centre Kurchatov Institute
Email: nurtdinov@list.ru
Ресей, pl. Akad. Kurchatova 1, Moscow, 123182
Қосымша файлдар
